BASG and healthcare professionals
News
#MedSafety Week 2023 - Every report counts. Call for patients and healthcare professionals to report suspected adverse reactions
messages in brief
|
06/11/2023
#MedSafetyWeek from November 6 to 12, 2023 - Reporting suspected adverse drug reactions helps to improve the safety of medicines. In a joint "MedSafetyWeek" campaign, pharmaceutical authorities around the world are reminding people how important it is to report suspected cases of adverse drug reactions. This year's campaign focuses on the important role of healthcare professionals and patients, who contribute to the safety of medicines by reporting suspected side effects.
#MedSafety Week 2023 - Every report counts. Call for patients and healthcare professionals to report suspected adverse reactions
Read more
Current issue of “RMS NEWS”
messages in brief
|
31/10/2023
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS”
Read more
CHESSMEN Board meets in Rome to discuss shortage prevention
messages in brief
|
20/10/2023
CHESSMEN Board meets in Rome to discuss shortage prevention.
CHESSMEN Board meets in Rome to discuss shortage prevention
Read more
Warning about counterfeit medicinal product Ozempic®
Safety warnings
|
messages in brief
|
12/10/2023
BASG informs about current developments and necessary measures in case of counterfeiting of the medicinal product Ozempic® in German presentation.
Warning about counterfeit medicinal product Ozempic®
Read more
Notification of pet products under Article 5(6) of Regulation (EU) 2019/6
messages in brief
|
03/10/2023
With the entry into force of Regulation (EU) 2019/6, medicinal products for certain pet animals, which were previously not subject to a marketing authorization requirement under Section 7(4) of the AMG, may now only be marketed in Germany if they have been notified to the BASG.
Notification of pet products under Article 5(6) of Regulation (EU) 2019/6
Read more